Annual Total Liabilities
$888.61 K
+$221.65 K+33.23%
September 30, 2024
Summary
- As of February 24, 2025, HQL annual total liabilities is $888.61 thousand, with the most recent change of +$221.65 thousand (+33.23%) on September 30, 2024.
- During the last 3 years, HQL annual total liabilities has fallen by -$9.86 million (-91.73%).
- HQL annual total liabilities is now -94.72% below its all-time high of $16.82 million, reached on September 30, 2022.
Performance
HQL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$888.61 K
+$8698.00+0.99%
September 30, 2024
Summary
- As of February 24, 2025, HQL quarterly total liabilities is $888.61 thousand, with the most recent change of +$8698.00 (+0.99%) on September 30, 2024.
- Over the past year, HQL quarterly total liabilities has stayed the same.
- HQL quarterly total liabilities is now -94.72% below its all-time high of $16.82 million, reached on September 30, 2022.
Performance
HQL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
HQL Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.2% | 0.0% |
| 3 y3 years | -91.7% | 0.0% |
| 5 y5 years | - | 0.0% |
HQL Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | +33.2% | -94.7% | +33.2% |
| 5 y | 5-year | -94.7% | +33.2% | -94.7% | +33.2% |
| alltime | all time | -94.7% | +33.2% | -94.7% | +33.2% |
Tekla Life Sciences Investors Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $888.61 K(+33.2%) | $888.61 K(+1.0%) |
| Mar 2024 | - | $879.91 K(+31.9%) |
| Sep 2023 | $666.96 K | $666.96 K(-93.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $10.04 M(-40.3%) |
| Sep 2022 | $16.82 M(+56.6%) | $16.82 M(+30.0%) |
| Mar 2022 | - | $12.94 M(+20.4%) |
| Sep 2021 | $10.75 M | $10.75 M |
FAQ
- What is Tekla Life Sciences Investors annual total liabilities?
- What is the all time high annual total liabilities for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors annual total liabilities year-on-year change?
- What is Tekla Life Sciences Investors quarterly total liabilities?
- What is the all time high quarterly total liabilities for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors quarterly total liabilities year-on-year change?
What is Tekla Life Sciences Investors annual total liabilities?
The current annual total liabilities of HQL is $888.61 K
What is the all time high annual total liabilities for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high annual total liabilities is $16.82 M
What is Tekla Life Sciences Investors annual total liabilities year-on-year change?
Over the past year, HQL annual total liabilities has changed by +$221.65 K (+33.23%)
What is Tekla Life Sciences Investors quarterly total liabilities?
The current quarterly total liabilities of HQL is $888.61 K
What is the all time high quarterly total liabilities for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly total liabilities is $16.82 M
What is Tekla Life Sciences Investors quarterly total liabilities year-on-year change?
Over the past year, HQL quarterly total liabilities has changed by $0.00 (0.00%)